E-cigarette use significantly increases a person’s risk of developing chronic lung diseases like asthma, bronchitis, emphysema or chronic obstructive pulmonary disease, according to new UC San Francisco research, the first longitudinal study linking e-cigarettes to respiratory illness in a sample representative of the entire U.S. adult population.
The study also found that people who used e-cigarettes and also smoked tobacco – by far the most common pattern among adult e-cigarette users – were at an even higher risk of developing chronic lung disease than those who used either product alone.
The findings were published Dec. 16, 2019 in the American Journal of Preventive Medicine and are based on an analysis of publicly available data from the Population Assessment of Tobacco and Health (PATH), which tracked e-cigarette and tobacco habits as well as new lung disease diagnoses in over 32,000 American adults from 2013 to 2016.
Though several earlier population studies had found an association between e-cigarette use and lung disease at a single point in time, these so-called cross-sectional studies provided a snapshot that made it impossible for researchers to say whether lung disease was being caused by e-cigarettes or if people with lung disease were more likely to use e-cigarettes.
By starting with people who did not have any reported lung disease, taking account of their e-cigarette use and smoking from the start, and then following them for three years, the new longitudinal study offers stronger evidence of a causal link between adult e-cigarette use and lung diseases than prior studies.
“What we found is that for e-cigarette users, the odds of developing lung disease increased by about a third, even after controlling for their tobacco use and their clinical and demographic information,” said senior author Stanton Glantz, Ph.D., a UCSF professor of medicine and director of the UCSF Center for Tobacco Control Research and Education.
“We concluded that e-cigarettes are harmful on their own, and the effects are independent of smoking conventional tobacco,” Glantz said.
Though current and former e-cigarette users were 1.3 times more likely to develop chronic lung disease, tobacco smokers increased their risk by a factor of 2.6.
For dual users – people who smoke and use e-cigarettes at the same time – these two risks multiply, more than tripling the risk of developing lung disease.
“Dual users – the most common use pattern among people who use e-cigarettes – get the combined risk of e-cigarettes and conventional cigarettes, so they’re actually worse off than tobacco smokers,” said Glantz.
This finding is particularly relevant as the debate continues to rage over whether e-cigarettes should be promoted as a harm-reduction tool for smokers.
While the authors found that switching from smoked tobacco to e-cigarettes lowered the risk of developing lung disease, fewer than 1 percent of the smokers had completely switched to e-cigarettes.
“Switching from conventional cigarettes to e-cigarettes exclusively could reduce the risk of lung disease, but very few people do it,” said Glantz.
“For most smokers, they simply add e-cigarettes and become dual users, significantly increasing their risk of developing lung disease above just smoking.”
Importantly, the results reported in this study are unrelated to EVALI (E-cigarette or Vaping Product Use-Associated Lung Injury), the acute lung disease first reported last summer, severe cases of which sent several e-cigarette users to the hospital and others to an early grave.
Though scientists are still working to determine the cause of EVALI, prior physiological studies in both animals and humans found that e-cigarettes suppress the immune system and increase the levels of stress-related proteins in the lungs.
And chemical analyses showed that e-cigarettes contain higher levels of certain toxic chemicals than conventional cigarettes. But the new study shows that these are not the only health threats posed by e-cigarettes.
“This study contributes to the growing case that e-cigarettes have long-term adverse effects on health and are making the tobacco epidemic worse,” said Glantz.
E-cigarettes have become increasingly popular and little is known about their potential adverse health effects.
Objectives: To determine the effects of e-cigarette use on the airways.
Methods: Induced sputum samples from cigarette smokers, e-cigarette users, and nonsmokers were analyzed by quantitative proteomics, and the total and individual concentrations of mucins MUC5AC and MUC5B were determined by light scattering/refractometry and labeled mass spectrometry, respectively. Neutrophil extracellular trap (NET) formation rates were also determined for the same groups.
Measurements and Main Results: E-cigarette users exhibited significant increases in aldehyde-detoxification and oxidative stress–related proteins associated with cigarette smoke compared with nonsmokers. The levels of innate defense proteins associated with chronic obstructive pulmonary disease, such as elastase and matrix metalloproteinase-9, were significantly elevated in e-cigarette users as well. E-cigarette users’ sputum also uniquely exhibited significant increases in neutrophil granulocyte–related and NET-related proteins, such as myeloperoxidase, azurocidin, and protein-arginine deiminase 4, despite no significant elevation in neutrophil cell counts. Peripheral neutrophils from e-cigarette users showed increased susceptibility to phorbol 12-myristate 13-acetate–induced NETosis. Finally, a compositional change in the gel-forming building blocks of airway mucus (i.e., an elevated concentration of mucin MUC5AC) was observed in both cigarette smokers and e-cigarette users.
Conclusions: Together, our results indicate that e-cigarette use alters the profile of innate defense proteins in airway secretions, inducing similar and unique changes relative to cigarette smoking. These data challenge the concept that e-cigarettes are a healthier alternative to cigarettes
New and emerging tobacco products, especially e-cigarettes, have become popular and their use has increased dramatically, particularly among the younger population, by attracting former tobacco smokers and never-smokers. This trend is supported by a common assumption that e-cigarette use is harmless and a safe alternative to cigarette smoking. Despite a lack of sufficient health science evidence, e-cigarettes are promoted as cigarette smoking cessation aids in some health care practices. Little is known about the potential adverse health effects of e-cigarette use on the lungs.What This Study Adds to the Field
To our knowledge, this is the first study using human airway samples to explore the effect/harm of e-cigarette use on the airways. This study describes a unique e-cigarette–induced innate lung response that includes markers of aberrant neutrophilic response and altered mucin secretion and indicates that the effects of e-cigarettes are overlapping with yet distinct from those observed in otherwise healthy cigarette smokers. These findings challenge the concept that switching from cigarettes to e-cigarettes is a healthier alternative.
The adverse health effects of long-term cigarette smoking in the lung (e.g., increased risks of cancer and chronic obstructive pulmonary disease [COPD]), have been well established (1), and public awareness regarding these risks is rising. Although this awareness has led to an ongoing trend of decreased usage of conventional tobacco products in the United States, new and emerging tobacco products, especially e-cigarettes, have been gaining popularity. These products have become popular and have recently shown dramatic increases (up to 900%) in use, particularly in the younger population, attracting both former tobacco smokers and never-smokers (2, 3). This trend is supported by the assumption by many that e-cigarette use is harmless and a safe alternative to cigarette smoking and by the fact that e-cigarettes are promoted as cigarette smoking cessation aids in certain health care practices, despite a lack of sufficient health science evidence (4).
E-cigarettes are designed to deliver nicotine to the brain via the lungs and cardiovascular system without the combustion of tobacco, which ordinarily results in the production of thousands of toxic compounds. However, vaporization of e-liquids by current-generation e-cigarette devices can generate similar toxic compounds, such as reactive aldehydes (5). The formation of toxic aldehydes (e.g., formaldehyde and acrolein) in e-cigarette vapors has been attributed to thermal decomposition of the major vehicle components of e-cigarette e-liquids (propylene glycol and glycerol) and flavorings, which are reported to produce levels that exceed occupational safety standards (6). Several of these toxic compounds (e.g., acrolein) are already associated with the epithelial response to cigarette smoking, specifically increasing mucin secretion (7–9).
E-cigarettes have recently been deemed to be subject to Food and Drug Administration regulation; however, specific aspects of their regulation are not yet in place, primarily because the potential adverse health effects and risks of e-cigarette use are still unknown. Therefore, it is of great importance to better understand how exposure to e-cigarette vapors modifies human airway biology compared with traditional cigarette smoking and to identify the potentially unique effects e-cigarette vapors might have on lung physiology.
The airway epithelial mucosal barrier is part of the innate immune system and protects the underlying epithelia when faced with microbial, physical, and chemical challenges (10), including smoking and vaping. The biophysical properties of airway mucus are primarily established by mucins MUC5B and MUC5AC and their interacting partners (11). Airway secretions from smokers and patients with COPD exhibits quantitative and compositional alterations, with observable changes in mucin concentration and the ratio of MUC5B to MUC5AC, signifying these mucins’ importance in the establishment of the biophysical properties of mucus (12, 13).
Neutrophils play an important role in airway maintenance because of their strong antimicrobial activity. However, when left unchecked, activated neutrophils can contribute to inflammatory lung diseases, such as COPD. Neutrophils exert their antimicrobial effects through four major mechanisms: 1) phagocytosis, 2) degranulation of stored mediators and enzymes, 3) reactive oxygen generation, and 4) the release of neutrophil extracellular traps (NETs) (14). NETs are the result of a specific type of cell death called NETosis (15) and consist of chromatin filaments and specific granule proteins, including neutrophil elastase (NE) and myeloperoxidase (MPO) (16), which have been associated with the bronchial inflammation and structural damage observed in diseases, such as cystic fibrosis and COPD (17, 18). Although NET formation is an antibacterial immune response, it has also been shown to be triggered by constituents of smoke and e-cigarette vapors, such as acrolein (19).
E-cigarettes are fairly new products, and data on the effects of their long-term use remain scarce. The airway epithelium is one of the first parts of the body encountered by inhaled smoke and vapors, and the mucus secretion layer acts as the first line of defense against inhaled biologic and chemical substances. Analysis of the changes in the airway secretion proteome as a result of e-cigarette vaping can identify potential biomarkers associated with adverse health effects. Using induced sputum samples from tobacco product users participating in the University of North Carolina Tobacco Center of Regulatory Science program, we compared changes in airway mucus composition and integrity among cigarette smokers, e-cigarette users, and healthy nonsmokers.
In this study, using induced sputum samples from cigarette smokers, e-cigarette users, and healthy never-smokers, we aimed to determine the effects of e-cigarettes on the human airways. Given that e-cigarette use–related changes in lung secretions are mostly unknown, we first focused on the known impacts of cigarette use. Comparing our results with published data, we were able to confirm changes in the levels of numerous proteins that are established markers of cigarette smoke exposure, thus validating our quantitative approach to identifying the effects on airways. We detected upregulation of the secreted detoxifying enzyme ALDH3A1, and the levels of other known in vivo and in vitro markers of cigarette smoke exposure (24, 25, 32, 33) were also elevated in the e-cigarette users, suggesting that e-cigarette exposure might be harmful for the lung as well. Additionally, the elevated levels of markers known to be associated with cigarette smoke and lung disease/inflammation, such as thioredoxin and MMP9, in the sputum of both cigarette smokers and e-cigarette users indicates commonality in the impacts of these products on airway physiology, such as increased oxidative stress and activation of innate defense mechanisms. Furthermore, proteases of neutrophil and epithelial origin, such as MMP9, are inflammatory mediators known to be major contributors to chronic lung diseases (34, 35).
As shown in Figure 3, increased levels of innate defense proteins secreted by the airway epithelium were observed in cigarette smokers. Several of these proteins, such as DMBT1, trefoil factor 3, lactoferrin, and LYSC, play important roles in protection against pathogens, either through direct antimicrobial activity or by acting as part of the mucosal barrier network. DMBT1 (11, 36) and trefoil factors (37) have been shown to interact with the building blocks of the mucus gel (i.e., gel-forming mucins) and can therefore potentially alter the viscoelastic properties of this important mechanical barrier (38). Interestingly, in the present study, the levels of these proteins tended to decrease in e-cigarette users; the levels of DMBT1 and LYSC, in particular, were significantly decreased in the e-cigarette users compared with the nonsmokers, suggesting an altered innate immune response in the former group.
The analysis of differentially expressed proteins revealed that a group of innate defense proteins of neutrophilic origin were highly represented in the e-cigarette users (Figures 1B and 1C). Most prominently, primary neutrophilic granule enzymes, such as NE, proteinase 3, and MPO, showed significantly higher levels in e-cigarette users than in nonsmokers (Figure 3). Among other functions, these neutrophilic enzymes are inflammatory mediators and major contributors to the pathogenesis of chronic lung diseases, such as COPD (34). Cell counts, however, showed no significant increase in the number of neutrophils in the sputum of e-cigarette users (Figure 5), suggesting that the changes were not caused by a greater number of neutrophils in these subjects.
Neutrophil granulocytes possess two major mechanisms for releasing stored mediators and enzymes to perform their antimicrobial activity: degranulation and the release of NETs (14). To gain insight into which of these mechanisms was most likely responsible for the observed proteome changes, we investigated the abundance of marker proteins associated with these processes in our dataset. The combined observations of elevated neutrophil-derived protein levels but no increase in neutrophil cell number in the sputum of e-cigarette users suggests two potential underlying pathogeneses: e-cigarettes may cause altered activation and degranulation of these neutrophils, or e-cigarettes may cause a neutrophilic increase but induce neutrophil death at the same time.
Extensive degranulation of neutrophils is a feature of lung disorders involving inflammation, such as severe asthma and COPD (17, 39). An additional mechanism by which neutrophil granulocytes can eliminate bacteria has been described by Brinkmann and coworkers (14). On activation by specific mediator signals, including cytokines, lipopolysaccharide, and specific complement factors (40), neutrophils were shown to form web-like extracellular structures called NETs. NETs are the product of a specific type of cell death called NETosis (15) and consist of chromatin filaments and specific globular proteins that are highly effective at trapping and killing invasive bacteria. In our proteomic analysis of sputum from tobacco product users, we were able to identify several proteins that have been shown to be associated with NETs (Figure 5). For example, in the sputum of e-cigarette users, we identified a significant increase in calprotectin (Figures 5A and 5B), a cytosolic protein in unstimulated neutrophils that is crucial for the clearance of infections when it is released as part of NETs (29). Other NET markers found to be significantly increased in our analysis include coronin-1 (Figure 5C) (30) and peptidylarginine deiminase 4 (Figure 5D), an enzyme known to modify histones that become part of NETs. Notably, histone H4 was identified among the proteins with the highest correlation with NE in our analysis, suggesting increased NET formation in e-cigarette users’ airways. Cytokines, such as IL-8 and tumor necrosis factor-α, are known mediators of NET formation (41, 42) but were not elevated in the e-cigarette users (data not shown).
The observation of elevated levels of neutrophil-derived proteins, including the proteins related to NET formation, in the absence of increased neutrophil cell numbers and cytokine levels indicates that the activation state of neutrophils is altered in the airways of e-cigarette users compared with nonsmokers and cigarette smokers. Indeed, the data also suggest that activation may be present systemically because peripheral blood neutrophils from e-cigarette users were more susceptible to PMA-induced NET formation. These data support the sputum proteomic data and are consistent with the findings of our previous study, which demonstrated that exposure of neutrophils to certain flavored e-liquids ex vivo also enhanced susceptibility to PMA-induced NET formation (22). Although the exact role of NET formation in respiratory disease is not known, aberrant activation of NET formation likely leads to the release of tissue-damaging proteases. Indeed, accumulation of NETs has been shown to be associated with inflammatory diseases, including cystic fibrosis and COPD (43, 44). The enhanced NET formation in peripheral blood neutrophils from e-cigarette users also suggests the potential for systemic harm beyond the lung. Given that increased NET formation is closely associated with epithelial and endothelial cell death and subsequent pathogenesis, aberrant NET formation in peripheral blood neutrophils from e-cigarette users should be examined in the context of the pathogenesis of systemic diseases, such as systemic lupus erythematosus (45), vasculitis (46), and psoriasis (45).
The secretion of elastase and other proinflammatory mediators by neutrophils has been observed in response to e-cigarette vapor extract exposure in vitro (47), indicating that e-cigarette constituents aberrantly activate neutrophils. Despite the enhanced secretion of elastase, e-cigarette-exposed mice showed a reduced ability to clear either bacteria or an influenza virus, suggesting that innate mucosal defense systems could be impaired by e-cigarette vapors (48). The consistent elevation of innate neutrophil defense protein levels in the e-cigarette users’ sputum in the present study suggests a vaping-induced increase in the inflammatory response of neutrophils in the airways that is distinct from the changes induced by cigarette smoke or more effective.
It is crucial to understand the acute and chronic effects of activated neutrophils and altered mucin secretion dynamics on the innate immune properties of airway secretions. The functional consequences of these alterations for the antibacterial and antioxidant defense mechanisms of the lung and their contributions to the pathogenesis of chronic lung diseases, such as COPD, remain to be elucidated.
Another key observation in this study is the marked increase in the gel-forming mucin MUC5AC in tobacco product users’ sputum, which led to an altered MUC5AC/MUC5B ratio. Increased MUC5AC has previously been associated with cigarette smoke exposure (7, 49), but the current study is the first to report an increase in this mucin in response to e-cigarette use. It has been suggested that an elevated mucin concentration is an important hallmark of failed mucus transport in mucoobstructive disease and an important parameter in COPD pathogenesis (13). Additionally, the ratio of the two major gel-forming mucins, MUC5AC and MUC5B, is related to mucus pathologies, including mucus stasis (12) and mucus obstruction (50). The MUC5AC concentration or the MUC5AC/MUC5B ratio of the airway secretions can therefore serve as a biomarker of exposure to and/or the effects of tobacco smoking.
It is important to note that most of the subjects in the studied e-cigarette user group (12 of 15) had smoked cigarettes at some time in their tobacco product use history before becoming predominant e-cigarette users. Therefore, the observed effects could have partly been a result of the users’ smoking history. However, it has been shown that the sputum proteomes of healthy former smokers are essentially similar to those of never-smokers (25) and that there is an absence of residual biomarkers of smoking in the sputum of former smokers. Future studies designed to study e-cigarette smokers who have never smoked cigarettes seem to be warranted.
To our knowledge, this the first study using human airway samples to explore the effect/harm of e-cigarette use on the airways. Our study clearly demonstrates a unique e-cigarette-induced innate lung response that includes markers of an aberrant neutrophilic response (Figure 8). Taken together, our results indicate that the effects of e-cigarettes are overlapping with and distinct from what is observed in otherwise healthy cigarette smokers. In conclusion, our results challenge the concept that e-cigarettes are a healthier alternative to cigarettes and reverse smoking-induced adverse health effects.
Figure 8.Schematic depiction of the impact of e-cigarette smoking on the airways. Vaping uniquely alters the airway innate immune response by causing an increase in the release of neutrophil extracellular trap–associated proteins; proteins involved in maintaining the redox balance of the airways; and the ratio of the building blocks of airway mucus, namely, the mucins MUC5AC and MUC5B. e-cig = e-cigarette.
More information:American Journal of Preventive Medicine (2019). www.ajpmonline.org/article/S07 … (19)30391-5/fulltext